These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1794264)

  • 1. Insulin resistance, insulin deficiency, and non-insulin-dependent diabetes mellitus.
    Cerasi E
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S37-45. PubMed ID: 1794264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 6 months' gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial CSII-induced normoglycemia.
    Della Casa L; del Rio G; Glaser B; Cerasi E
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S69-78. PubMed ID: 1794269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 6-month gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial continuous subcutaneous insulin infusion-induced normoglycemia.
    Della Casa L; del Rio G; Glaser B; Cerasi E
    Am J Med; 1991 Jun; 90(6A):37S-45S. PubMed ID: 1872303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-BM 13.0913: a new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non-insulin-dependent) diabetes mellitus.
    Freund P; Wolff HP; Kühnle HF
    Metabolism; 1995 May; 44(5):570-6. PubMed ID: 7752903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
    Reaven GM
    Diabetes Care; 1984; 7 Suppl 1():17-24. PubMed ID: 6376025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin on glucose utilization in epitrochlearis muscle of rats with streptozocin-induced NIDDM.
    Karl IE; Gavin JR; Levy J
    Diabetes; 1990 Sep; 39(9):1106-15. PubMed ID: 2200730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular defects in glucose metabolism in obese patients with NIDDM.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a new model of NIDDM.
    Sato T; Asahi Y; Toide K; Nakayama N
    Diabetologia; 1995 Sep; 38(9):1033-41. PubMed ID: 8591816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIDDM in the elderly.
    Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
    Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the pathogenesis of type 2 diabetes: can we get off the metabolic merry-go-rounds?
    Proietto J; Andrikopoulos S; Rosella G; Thorburn A
    Aust N Z J Med; 1995 Dec; 25(6):870-5. PubMed ID: 8770366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of exercise intensity on glucose and insulin metabolism in obese individuals and obese NIDDM patients.
    Kang J; Robertson RJ; Hagberg JM; Kelley DE; Goss FL; DaSilva SG; Suminski RR; Utter AC
    Diabetes Care; 1996 Apr; 19(4):341-9. PubMed ID: 8729157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity.
    Ueda H; Ikegami H; Yamato E; Fu J; Fukuda M; Shen G; Kawaguchi Y; Takekawa K; Fujioka Y; Fujisawa T
    Diabetologia; 1995 May; 38(5):503-8. PubMed ID: 7489831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus.
    Friedman JE; Caro JF; Pories WJ; Azevedo JL; Dohm GL
    Metabolism; 1994 Aug; 43(8):1047-54. PubMed ID: 8052146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat.
    Hamann A; Benecke H; Le Marchand-Brustel Y; Susulic VS; Lowell BB; Flier JS
    Diabetes; 1995 Nov; 44(11):1266-73. PubMed ID: 7589822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects.
    Ferrannini E
    Endocr Rev; 1998 Aug; 19(4):477-90. PubMed ID: 9715376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.